Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by JUAN LOPEZ-MATTEI and SAAMIR A HASSAN.
JUAN LOPEZ-MATTEI
Connection Strength
3.388
SAAMIR A HASSAN
  1. Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy. Front Cardiovasc Med. 2021; 8:734820.
    View in: PubMed
    Score: 0.202
  2. Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis. Front Cardiovasc Med. 2021; 8:626414.
    View in: PubMed
    Score: 0.198
  3. QT Prolongation in Cancer Patients. Front Cardiovasc Med. 2021; 8:613625.
    View in: PubMed
    Score: 0.193
  4. Prevalence of pulmonary hypertension in myelofibrosis. Ann Hematol. 2020 Apr; 99(4):781-789.
    View in: PubMed
    Score: 0.180
  5. Carcinoid Heart Disease: a Comprehensive Review. Curr Cardiol Rep. 2019 11 19; 21(11):140.
    View in: PubMed
    Score: 0.177
  6. The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics. Methodist Debakey Cardiovasc J. 2019 Oct-Dec; 15(4):258-266.
    View in: PubMed
    Score: 0.175
  7. Cardiac toxicities of anticancer treatments: chemotherapy, targeted therapy and immunotherapy. Curr Opin Cardiol. 2019 07; 34(4):441-450.
    View in: PubMed
    Score: 0.172
  8. Multimodality imaging in carcinoid heart disease. Open Heart. 2019; 6(1):e001060.
    View in: PubMed
    Score: 0.171
  9. Cardiovascular manifestations of Erdheim-Chester disease. Echocardiography. 2019 02; 36(2):229-236.
    View in: PubMed
    Score: 0.166
  10. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart. 2018; 5(2):e000881.
    View in: PubMed
    Score: 0.163
  11. Evaluation and Management of Cardiac Tumors. Curr Treat Options Cardiovasc Med. 2018 Mar 20; 20(4):29.
    View in: PubMed
    Score: 0.158
  12. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep. 2018 02 08; 20(2):10.
    View in: PubMed
    Score: 0.156
  13. The role of cardiac MRI in cardio-oncology. Future Cardiol. 2017 07; 13(4):311-316.
    View in: PubMed
    Score: 0.150
  14. Carcinoid heart disease. Heart. 2017 10; 103(19):1488-1495.
    View in: PubMed
    Score: 0.149
  15. Improved reliability in left ventricular ejection fraction assessment by adopting quantitative methods. Echocardiography. 2016 Dec; 33(12):1936-1937.
    View in: PubMed
    Score: 0.144
  16. Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the "forgotten pulmonic valve". Front Cardiovasc Med. 2022; 9:1071138.
    View in: PubMed
    Score: 0.055
  17. Bioprosthetic valve monitoring in patients with carcinoid heart disease. Front Cardiovasc Med. 2022; 9:1072890.
    View in: PubMed
    Score: 0.055
  18. Trigger related outcomes of takotsubo syndrome in a cancer population. Front Cardiovasc Med. 2022; 9:1019284.
    View in: PubMed
    Score: 0.054
  19. Fractional Flow Reserve Cardio-Oncology Effects on Inpatient Mortality, Length of Stay, and Cost Based on Malignancy Type: Machine Learning Supported Nationally Representative Case-Control Study of 30 Million Hospitalizations. Medicina (Kaunas). 2022 Jun 28; 58(7).
    View in: PubMed
    Score: 0.053
  20. Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med. 2022; 9:916325.
    View in: PubMed
    Score: 0.053
  21. Stress cardiomyopathy in hospitalized patients with cancer: machine learning analysis by primary malignancy type. ESC Heart Fail. 2021 12; 8(6):4626-4634.
    View in: PubMed
    Score: 0.050
  22. Interventional Strategies in Cancer-induced Cardiovascular Disease. Curr Oncol Rep. 2021 09 27; 23(11):133.
    View in: PubMed
    Score: 0.050
  23. How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience. JACC CardioOncol. 2021 Sep; 3(3):452-456.
    View in: PubMed
    Score: 0.050
  24. Cancer treatment resumption in patients with new-generation drug-eluting stents. Coron Artery Dis. 2021 Jun 01; 32(4):295-301.
    View in: PubMed
    Score: 0.049
  25. Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography. Front Cardiovasc Med. 2020; 7:9.
    View in: PubMed
    Score: 0.045
  26. Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol. 2019 08; 19(4):382-387.
    View in: PubMed
    Score: 0.043
  27. The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis? Curr Cardiol Rep. 2019 07 08; 21(8):83.
    View in: PubMed
    Score: 0.043
  28. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol. 2019 04 15; 123(8):1351-1357.
    View in: PubMed
    Score: 0.042
  29. The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment. Oncol Lett. 2019 May; 17(5):4126-4132.
    View in: PubMed
    Score: 0.041
  30. Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. Front Cardiovasc Med. 2018; 5:48.
    View in: PubMed
    Score: 0.040
  31. Evolution of echocardiography in subclinical detection of cancer therapy-related cardiac dysfunction. Echocardiography. 2018 06; 35(6):860-868.
    View in: PubMed
    Score: 0.040
  32. Stress-Induced Cardiomyopathy in Cancer Patients. Am J Cardiol. 2017 Dec 15; 120(12):2284-2288.
    View in: PubMed
    Score: 0.038
  33. Cardiac amyloidosis. Expert Rev Cardiovasc Ther. 2014 Feb; 12(2):265-77.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.